Tamoxifen, serum lipoproteins and cardiovascular risk

British Journal of Cancer

Volumn 58, Issue 4, 1988, Pages 497-499

  Bruning, P F ^a   G Bonfrer, J M ^a   M Hart, A A ^a   De Jong Bakker, M ^a   Linders, D ^a   Van Loon, J ^a   Nooyen, W J ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; RADIOISOTOPE; SEX HORMONE BINDING GLOBULIN; TAMOXIFEN;

BLOOD LEVEL; BREAST CANCER; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; THYROXINE BINDING;

ADULT; AGED; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CHOLESTEROL; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMAN; LIPOPROTEINS; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; MIDDLE AGE; SEX HORMONE-BINDING GLOBULIN; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN; THYROXINE; TRIGLYCERIDES;

EID: 0023700859     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.248     Document Type: Article

References (23)

1. ANONYMOUS, L. (1987). Adjuvant tamoxifen in the management of operable breast cancer: the Scottish trial. Report of the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Lancet, 2, 171.
2. BAIN, C., WILLET, W., HENNEKENS, C.H. & 3 others (1981). Use of postmenopausal hormones and risk of myocardial infarction. Circulation, 64, 42.
3. BRUNING, P.F., BONFRER, J.M.G., DE JONG-BAKKER, M. & NOOYEN, W. (1984). Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer. J. Steroid Biochem., 21, 293.
4. BRUNING, P.F., BONFRER, J.M.G., DE JONG-BAKKER, M., LINDERS, D. & VAN LOON, J. (1987). Tamoxifen, serum-lipoproteins and cardiovascular risk. 4th EORTC Breast Cancer Working Conf., London. Abstract B 2.3.
5. BRUNNER, D., WEISBORT, J., MESHULAM, N. & 5 others (1987). Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv prospective Coronary Artery Disease Study. Am. J. Cardiol., 59, 1271.
6. BURSTEIN, M., SCHOLNICK, H.R. & MORFIN, R. (1970). Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res., 11, 583.
7. CUZICK, J., WANG, D.Y. & BULBROOK, R.D. (1986). The prevention of breast cancer. Lancet, 1, 83.
8. FAHRAEUS, L., LARSSON-COHN, U. & WALLENTIN, L. (1982). Lipoproteins during oral and cutaneous administration of oestradiol-17-f to menopausal women. Acta Endocrinol., 101, 597.
9. FEX, G., ADIELSSON, G. & MATTSON, W. (1981). Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol., 97, 109.
10. FRIE-DEWALD, W.T., LEVY, R.I. & FREDERICKSON, D.S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18, 499.
11. GORDON, T., KANNEL, W.B., MARTHANA, F.A.C.P., HJORTLAND, C. & MCNAMARA, P. (1978). Menopause and coronary heart disease. Ann. Int. Med., 89, 157.
12. GRUNDY, S.M., GREENLAND, P.H., HERD, A. & 4 others (1987). Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association. Circulation, 75, 1340A.
13. KRAUSS, R.M. (1982). Regulation of high density lipoprotein levels. Med. Clin. North Am., 66, 403.
14. LEVY, R.I. (1981). Cholesterol, lipoproteins, apoproteins, and heart disease: Present status and future prospects. Clin. Chem. 27, 653.
15. LEVY, R.I. (1983). Current status on the cholesterol controversy. Am. J. Med., 74, 1.
16. LOPES-VIRELLA, M.F., STONE, P., ELLIS, S. & 4 others (1977). Cholesterol determination in high-density lipoproteins separated by three different methods. Clin. Chem., 23, 882.
17. MOURIDSEN, H., PALSHOF, T., PATTERSON, J. & BATTERSBY, L. (1978). Tamoxifen in advanced breast cancer. Cancer Treat. Rev., 5, 131.
18. PATTERSON, J., FURR, B., WAKELING, A. & BATTERSBY, L. (1982). The biology and physiology of "Nolvadex" (tamoxifen) in the treatment of breast cancer. Breast Cancer Res. Treat., 2, 363.
19. REGOUW, B.J.M., CORNELISSEN, P.J.H.C., HELDER, R.A.P., SPIJKERS, J.B.F. & WEEBER, Y.M.M. (1971). Specific determination of free fatty acid in plasma. Clin. Chim. Acta, 31, 187.
20. ROSENBERG, L., HENNEKENS, C.H., ROSNER, B. & 4 others (1981). Early menopause and the risk of myocardial infarction. Am. J. Obstet. Gynecol., 139, 47.
21. ROSS, R.K., PAGANI-NIHILL, A., MACK, T.M., ARTHUR, M. & HENDERSON, B.E. (1981). Menopausal oestrogen therapy and protection from death from ischaemic heart disease, Lancet, 1, 858.
22. ROSSNER, S. & WALLGREN, A. (1984). Serum lipoproteins after breast cancer surgery and effects of tamoxifen. Atherosclerosis, 53, 339.
23. WILSON, P.W.F., CASTELLI, W.P. & KANNEL, W.B. (1987). Coronary risk prediction in adults (The Framingham heart study). Am. J. Cardiol., 59, 91 G.